Saratov JOURNAL of Medical and Scientific Research

Biomolecular assessment of renal function in various types of surgical treatment of renal cell carcinoma

Year: 2017, volume 13 Issue: №1 Pages: 73-77
Heading: Traumatology and Orthopedics Article type: Original article
Authors: Popkov V.M., Tarasenko A.l., Maslyakova G.N., Rossolovsky A.N., Zakharova N.B., Berezinets O.L., Lomakin D.V.
Organization: First Moscow State Medical University n.a. I.M. Sechenov, Saratov State Medical University

Objective: to assess the possibility of using the markers of acute kidney injury to predict the preoperative risk for the subsequent decline in glomerular filtration rate in different types of surgical treatment of renal cell carcinoma (RCC). Material and methods. 60 patients with histologically confirmed RCC T1-3M0N0 operated in the clinic of urology of Saratov State Medical University n.a. V. I. Razumovsky in the volume of nephrectomy or partial nephrectomy. Before surgery all patients underwent standard examination intended for patients with kidney tumors: ultrasound, MRI, excretory urography and dynamic renoscintigraphy, the perioperative values of serum creatinine and glomerular filtration rate were determined. Using the method of immuno-enzymatic analysis the concentrations of excreted with the urine NGAL and IL-18 in serum samples at the preoperative stage, after 5 days and after 1 month of postoperative follow-up were investigated. Differences in clinical data and clinical variables were compared by using Spearman rank correlations and t-test. Results. The determined parameters of acute kidney injury markers IL-18 and NGAL in the early postoperative period were increased in patients after open nephrectomy. Moreover, the correlation analysis according to the Spearman method revealed a strong significant correlation between the preoperative levels of IL-18 and GFR after surgery (r=1; p<0.05). Conclusion. Laparoscopic resection of RCC is the method of choice for surgical treatment of RCC. As a predictor of adverse prognosis, the level of IL-18 in serum may be used. Its increase correlates with a decline in renal function in the postoperative period, and according to some reports, IL-18 also is an independent predictor of adverse prognosis in patients with a localized RCC.

1. Solarek W, Czarnecka AM, Escudier B. Insulin and IGFs in renal cancer risk and progression. Endocr Relat Cancer 2015 Oct; 22 (5): 253-64
2. Chinello C, L'imperio V, Stella M. The proteomic landscape of renal tumors. Expert Rev Proteomics 2016; 13 (12): 1103-1120
3. Alyaev YuG, Glybochko PV, Grigoryan ZG, et al. Organ-preserving kidney tumor operations. M.: GEOTAR-media, 2009; 264 p.
4. TraczAF, Szczylik С, Porta С, Czarnecka AM. Insulin-like growth factor-1 signaling in renal cell carcinoma. ВМС Cancer 2016; 16(1): 453
5. Hasanov MZ, Batyushin MM, Terentyev VP, et al. Molecular aspects of the pathogenesis of kidney cancer. Basic Research 2012; 12 (2): 244-249
6. Kozachenko AV. Tread and regenerative therapy for acute and chronic kidney damage: DSc abstract. M., 2009
7. Ariarajah N, Gerstel Е, Martin PY, Ponte В. Biomarkers in acute kidney injury: an update. Rev Med Suisse 2011; 7 (284): 490-4
8. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury Network. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; (11): 31
9. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006; 10 (3): 73
10. Rosner MH. Urinary biomarkers for the detection of renal injury. Adv Clin Chem 2009; (49): 73-97
11. Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol 2008; 23 (12): 2151-7
12. Waanders F, Timmeren MM van, Stegeman CA, et al. Kidney injury molecule-1 in renal disease. J Pathol 2010; 220 (1): 7-16
13. Maslyakova GN., Rossolovsky AN., Napsheva AM., Zakharova NB. Assessment tubulointerstitial changes in the renal parencyyma in the surgical treatment of nephrolithiasis. Messenger of urology 2014; (1): 3-10
14. Dieterle F, Sistare F, Goodsaid F, et al. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat Biotechnol 2010; (28): 455-462
15. Huang WC, Atoria CL, Bjurlin M, et al. Management of small kidney cancers in the new millennium: contemporary trends and outcomes in a population-based cohort. JAMA Surgery 2015; 150 (7): 664-672
16. Meeks JJ, Gonzalez CM. Standard of care for small renal masses in the 21st century. JAMA Surgery 2015; 150 (7): 672-673
17. Ha SC, Zlomke HA, Cost N, Wilson S. The Past, Present, and Future in Management of Small Renal Masses. J Oncol 2015; (20): 364807
18. Kim SH, Lee SE, Hong SK, et al. Incidence and risk factors of chronic kidney disease in korean patients with T1 a renal cell carcinoma before and after radical or partial nephrectomy Jpn J Clin Oncol 2013; (43): 1243-1248
19. Huang WC, Elkin EB, Levey AS, et al. Partial nephrectomy versus radical nephrectomy in patients with small renal tumors — is there a difference in mortality and cardiovascular outcomes? J Urol 2009; (181): 55-61
20. Rini Bl, Campbell SC, Escudier B. Renal cell carcinoma. Lancet 2009; 373 (9669): 1119-1132
21. Ghoneim TP, Sjoberg DD, Lowrance W. Partial nephrectomy for renal tumors in solitary kidneys: postoperative renal function dynamics. World J Urol 2015 Dec; 33 (12): 2023-9
22. Simhan J, Smaldone MC, Tsai KJ, et al. Objective measures of renal mass anatomic complexity predict rates of major complications following partial nephrectomy. European Urology 2011; 60 (4): 724-730
23. Scosyrev E, Messing EM, Sylvester R, et al. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904. European Urology 2014; 65 (2): 372-377
24. Kim CS, Bae EH, Ma SK. Impact of partial nephrectomy on kidney function in patients with renal cell carcinoma. ВМС Nephrol2014; 19(15): 181
25. Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; (365): 1231 -1238
26. Wagener G, Jan M, Kim M, et al: Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 2006; (105): 485-491
27. Mishra J, Ma Q, Kelly C, et al: Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol, 2006; (21): 856-863
28. Supavekin S, Zhang W, Kucherlapati R, et al. Differential gene expression following early renal ischemia/ reperfusion. Kidney Int2003; (63): 1714-1724
29. Rossolovsky AN, Glybochko PV, Popkov VM, Polozov AB, Ponukalin AN, Zakharova NB, Berezinetz OL, Blumberg Bl. Molecular markers of acute kidney injury and fibrosis in the estimation of the functional condition of kidneys in the patients with nephrolithiasis Bashkortostan medical journal 2010; (5): 31-38
30. Lisowska-Myjak B. Serum and urinary biomarkers of acute kidney injury. Blood Purif 2010; 4 (29): 357-65
31. Zang ZD, Huang YZ, Yang Y, Guo FM, Qiu HB. Urinary neutrophil gelatinase-associated lipocalin and urinary interleukin-18 in early diagnosis of acute kidney injury in critically ill patients. Zhonghua Nei Ke Za Zh 2010; 5 (49): 396-399
32. Parikh CR, Jani A, Melnikov VY, et al. Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis Lane BR. Molecular markers of kidney injury. Urol Oncol 2011; 30 (43): 405-414
33. Urbschat A, Nicholas Obermuller N, HaferkampA. Biomarkers of kidney injury 2011; 16(1): 22-30
34. The Ha SC, Zlomke HA, Cost N, et al. Past, Present, and Future in Management of Small Renal Masses. J Oncol 2015; 20 (15): 364.

2017_01_073-077.pdf628.86 KB

No votes yet